What is the prevalence of hepatic steatosis on ultrasonography in patients followed for nephrolithiasis?

Authors

  • David-Dan Nguyen Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada
  • David Bouhadana Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada
  • Philip Wong Division of Gastroenterology & Hepatology, Department of Medicine, McGill University Health Center, Montreal, QC, Canada
  • Sero Andonian Division of Urology, Department of Surgery, McGill University Health Center, Montreal, QC, Canada

DOI:

https://doi.org/10.5489/cuaj.7767

Keywords:

Nephrolithiasis, Non-alcoholic Fatty Liver Disease, Ultrasound, Disease Prevention

Abstract

Introduction: Patients with non-alcoholic fatty liver disease (NAFLD) have higher prevalence of nephrolithiasis. The aim of the present study was to determine prevalence of hepatic steatosis on ultrasonography in nephrolithiasis patients.

Methods: Charts of 318 consecutive nephrolithiasis patients seen in stone clinic between January and February 2018 were retrospectively reviewed. Ultrasound reports were reviewed for hepatic steatosis. Subsequent liver investigations were noted. Patients’ demographic predictors of hepatic steatosis were identified using univariable logistic regression models.

Results: A total of 162 patients was included, of which 76 (46.9%) were found to have hepatic steatosis and 22 (13.6%) were found to have moderate-to-severe hepatic steatosis. Median followup was 2.03 years. Predictors of hepatic steatosis included higher body mass index and smoking (both p<0.05). Progression of fatty liver on ultrasound was noted for 13 (17.1%) and regression was noted for two (2.6%). Of the 16 patients with a Fibrosis-4 (FIB-4) score, four (25.0%) patients required further investigation and 12 (75.0%) were unlikely to have advanced fibrosis. Of 12 patients who underwent fibroscan, one (8.3%) had both fibrosis and cirrhosis, two (16.7%) fibrosis only, and two (16.7%) moderate-to-severe steatosis.

Conclusions: Hepatic steatosis on ultrasound followup of nephrolithiasis patients is common, especially in smokers and overweight patients. Current recommendations suggest that primary care physicians calculate a FIB-4 score upon the detection of hepatic steatosis on ultrasound. The decision to refer to hepatology f

Downloads

Download data is not yet available.

Downloads

Published

2022-07-21

How to Cite

Nguyen, D.-D., Bouhadana, D., Wong, P., & Andonian, S. (2022). What is the prevalence of hepatic steatosis on ultrasonography in patients followed for nephrolithiasis?. Canadian Urological Association Journal, 16(12), 442–6. https://doi.org/10.5489/cuaj.7767

Issue

Vol. 16 No. 12 (2022): CUAJ December

Section

Research Letter

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.